Skip to main content

Advertisement

Log in

Alpha-Synuclein Transmission and Mitochondrial Toxicity in Primary Human Foetal Enteric Neurons In Vitro

  • Original Article
  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Parkinson’s disease (PD) is a multicentred neurodegenerative disorder characterised by the accumulation and aggregation of alpha-synuclein (α-syn) in several parts of the central nervous system. However, it is well established that PD can generate symptoms of constipation and other gastrointestinal problems and α-syn containing lesions have been identified in intestinal nerve cells. In this study, we show that α-syn can be taken up and accumulate in primary human foetal enteric neurons from the gastrointestinal tract and can be transferred between foetal enteric neurons. Impaired proteosomal/lysosomal degradation can promote the uptake and accumulation of α-syn in enteric neurons. Enteric neurons exposed to α-syn can also lead to impaired mitochondrial complex I activity, reduced mitochondrial function, and NAD+ depletion culminating in cell death via energy restriction. These findings demonstrate neuron-to-neuron transmission of α-syn in enteric neurons, providing renewed evidence for Braak’s hypothesis and the aetiology of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, Greene JG (2012) Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 124(5):665–680

    Article  PubMed Central  PubMed  Google Scholar 

  • Bahr B, Bendiske J (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83:481–489

    Article  CAS  PubMed  Google Scholar 

  • Beach TG, Adler C, Sue L, Vedders L, Lue L, White l (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689–702

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–366

    Article  CAS  PubMed  Google Scholar 

  • Beal MF (2003) Mitochondria, oxidative damage, and inflammation in Parkinson’s disease. Ann N Y Acad Sci 991:120–131

    Article  CAS  PubMed  Google Scholar 

  • Beal MF (2007) Mitochondria and neurodegeneration. Novartis Found Symp 287:183–192 discussion 192–186

    Article  CAS  PubMed  Google Scholar 

  • Bernofsky C, Swan M (1973) An improved cycling assay for nicotinamide adenine dinucleotide. Anal Biochem 53:452–458

    Article  CAS  PubMed  Google Scholar 

  • Bottner M, Zorenkov D, Hellwig I, Barrenschee M, Harde J, Fricke T, Deuschl G, Egberts JH, Becker T, Fritscher-Ravens A, Arlt A, Wedel T (2012) Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol Dis 48(3):474–480

    Article  PubMed  Google Scholar 

  • Braak H, de Vos R, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett 396:67–72

    Article  CAS  PubMed  Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 53:452–458

    Google Scholar 

  • Braidy N, Guillemin G, Grant R (2008) Promotion of cellular NAD+ anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer’s disease. Neurotox Res 13:173–184

    Article  CAS  PubMed  Google Scholar 

  • Braidy N, Guillemin G, Chan-Ling MHT, Poljak A, Grant R (2011) Age related changes in NAD+ metabolism, oxidative stress and Sirt1 activity in Wistar rats. PLoS One 6(4):e19194

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Broe M, Shepherd CE, Mann DM, Milward EA, Gai WP, Thiel E, Halliday GM (2005) Insoluble alpha-synuclein in Alzheimer’s disease without Lewy body formation. Neurotox Res 7(1–2):69–76

    Article  CAS  PubMed  Google Scholar 

  • Budd SL, Nicholls DG (1996) Mitochondria, calcium regulation, and acute glutramate excitotoxicity in cultured cerebellar granule cells. J Neurochem 67:2282–2291

    Article  CAS  PubMed  Google Scholar 

  • Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton M, Sudhof T (2010) Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329:1663–1667

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Caughey B (2000) Transmissible spongiform encephalopathies, amyloidoses and yeast prions: common threads? Nat Med 6:751–754

    Article  CAS  PubMed  Google Scholar 

  • Chong ZZ, Li F, Maiese K (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75(3):207–246

    Article  CAS  PubMed  Google Scholar 

  • Desplats P, Lee H-J, Bae E, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106:13010–13015

    Article  CAS  PubMed  Google Scholar 

  • Esteves A, Arduino D, Silva D, Oliveira C, Cardoso S (2010) Mitochondrial dysfunction: the road to Alpha-Synuclein oligomerisation in PD. Parkinson’s Dis 2011:1–20

    Article  Google Scholar 

  • Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortes M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, Villemagne VL (2007) In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci 27(39):10365–10371

    Article  CAS  PubMed  Google Scholar 

  • Fornai F, Lenzi P, Gesi M, Ferrucci M, Lazzeri G, Busceti CL, Ruffoli R, Soldani P, Ruggieri S, Alessandri MG, Paparelli A (2003) Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition. J Neurosci 23(26):8955–8966

    CAS  PubMed  Google Scholar 

  • Frost B, Jacks R, Diamond M (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284:12845–12852

    Article  CAS  PubMed  Google Scholar 

  • Gitler A, Chesi A, Geddie M, Strathearn K, Hamamichi S, Hill K, Caldwell K, Caldwell G, Cooper A, Rochet J, Lindquist S (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41:308–315

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Goetze O, Woitalla D (2008) The role of MPTP in Parkinson’s disease: connecting brain and gut? Exp Neurol 210(2):281–285

    Article  CAS  PubMed  Google Scholar 

  • Gold A, Turkalp ZT, Munoz DG (2013) Enteric alpha-synuclein expression is increased in Parkinson’s disease but not Alzheimer’s disease. Mov Disord 28(2):237–240

    Article  CAS  PubMed  Google Scholar 

  • Grant RS, Kapoor V (1998) Murine glial cells regenerate NAD, after peroxide-induced depletion, using either nicotinic acid, nicotinamide, or quinolinic acid as substrates. J Neurochem 70:1759–1763

    Article  CAS  PubMed  Google Scholar 

  • Guillemin G, Smythe G, Takikawa O, Brew BJ (2004) Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons. Glia 49:15–23

    Article  Google Scholar 

  • Halliday G, McCann H (2008) Human-based studies on alpha-synuclein deposition and relationship to Parkinson’s disease symptoms. Exp Neurol 2008:12–21

    Article  Google Scholar 

  • Hansen C, Angot E, Bergstrom A-L, Steiner J, Pieri L, Paul G, Outeiro T, Melki R, Kallunki P, Fog K, Li J-Y, Brundin P (2011) Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121:715–725

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jensen PH, Islam K, Kenney J, Nielsen MS, Power J, Gai WP (2000) Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. J Biol Chem 275(28):21500–21507

    Article  CAS  PubMed  Google Scholar 

  • Keeney P, Xie J, Capaldi R, Benenett J (2006) Parkinson’s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci Res 26:5256–5264

    CAS  Google Scholar 

  • Koh JY, Choi DW (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20:83–90

    Article  CAS  PubMed  Google Scholar 

  • Lebouvier T, Chaumette T, Damier P, Coron E, Touchefeu Y, Vrignaud S, Naveilhan P, Galmiche JP, Varannes SBD, Derkinderen P, Neunlist M (2008) Pathological lesions in colonic biopsies during Parkinson’s disease. Gut 57(12):1741–1743

    Article  CAS  PubMed  Google Scholar 

  • Lebouvier T, Neunlist M, des Varannes SB, Coron E, Drouard A, N’Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P (2010) Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms. PLoS One 5(9):e12728

    Article  PubMed Central  PubMed  Google Scholar 

  • Lee H-J, Suk J, Bae E, Lee S-J (2008) Clearance and deposition of extracellular alpha-synuclein aggregates in microglia. Biochem Biophys Res Commun 372:423–428

    Article  CAS  PubMed  Google Scholar 

  • Lesage S, Brice A (2009) Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:R48–R59

    Article  CAS  PubMed  Google Scholar 

  • Lin M, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787–795

    Article  CAS  PubMed  Google Scholar 

  • Massudi H, Grant R, Guillemin G, Braidy N (2012) NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Rep 17:28–46

    Article  CAS  PubMed  Google Scholar 

  • Meyer-Luehmann M, Coomaraswarmy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton A, Vigouret J, Paganetti P, Walsh D, Mathews P, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781–1784

    Article  CAS  PubMed  Google Scholar 

  • Mi K, Soon J, Poncz K, Song J, Kwang S (2007) Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med 9:376–384

    Google Scholar 

  • Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Ova H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson’s disease. Biochem Biophys Res Commun 163:1450–1455

    Article  CAS  PubMed  Google Scholar 

  • Mrak RE, Griffin WS (2007) Common inflammatory mechanisms in Lewy body disease and Alzheimer disease. J Neuropathol Exp Neurol 66(8):683–686

    Article  CAS  PubMed  Google Scholar 

  • Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K, Munishkina L, Zhang J, Gardner B, Wakabayashi J, Sesaki H, Cheng Y, Finkbeiner S, Nussbaum RL, Masliah E, Edwards RH (2011) Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 286(23):20710–20726

    Article  CAS  PubMed  Google Scholar 

  • Natale G, Pasquali L, Ruggieri S, Paparelli A, Fornai F (2008) Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil 20(7):741–749

    Article  CAS  PubMed  Google Scholar 

  • Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, Fornai F (2010) MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res 1355:195–206

    Article  CAS  PubMed  Google Scholar 

  • Natale G, Ferrucci M, Lazzeri G, Paparelli A, Fornai F (2011a) Transmission of prions within the gut and towards the central nervous system. Prion 5(3):142–149

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Natale G, Pasquali L, Paparelli A, Fornai F (2011b) Parallel manifestations of neuropathologies in the enteric and central nervous systems. Neurogastroenterol Motil 23(12):1056–1065

    Article  CAS  PubMed  Google Scholar 

  • Outeiro T, Putcha P, Tetzlaff J, Spoelgen R, Koker M, Carvalho F, Hyman B, McLean P (2008) Formation of toxic oligomeric alpha-synuclein species in living cells. PLoS One 3:e1867

    Article  PubMed Central  PubMed  Google Scholar 

  • Pan T, Kondo S, Le W, Jankovic J (2008) The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease. Brain 131:1969–1978

    Article  PubMed  Google Scholar 

  • Pesta D, Gnaiger E (2012) High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 810:25–58

    Article  CAS  PubMed  Google Scholar 

  • Phillips R, Walter G, Wilder S, Baronowsky E, Powley T (2008) Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson’s disease? Neuroscience 153:733–750

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Phillips R, Walter G, Ringer B, Higgs K, Powley T (2009) Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging fischer 344 rat. Exp Neurol 220:109–119

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276(5321):2045–2047

    Article  CAS  PubMed  Google Scholar 

  • Raghavan R, de Kruijff L, Sterrenburg MD, Rogers BB, Hladik CL, White CL (2004) Alpha-synuclein expression in the developing human brain. Pediatr Dev Pathol 7(5):506–516

    Article  PubMed  Google Scholar 

  • Ren P, Laukner J, Kachirskaia I, Heuser J, Melki R, Kopito R (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11:219–225

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rodgers K, Dean R (2003) Assessment of proteosome activity in cell lysates and tissue homogenates using peptide substrates. Int J Biochem Cell Biol 35:716–727

    Article  CAS  PubMed  Google Scholar 

  • Sas K, Robotka H, Toldi J, Vecsei L (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257(1–2):221–239

    Article  CAS  PubMed  Google Scholar 

  • Sayre LM, Moreira PI, Smith MA, Perry G (2005) Metal ions and oxidative protein modification in neurological disease. Ann Ist Super Sanita 41(2):143–164

    CAS  PubMed  Google Scholar 

  • Schapira A, Cooper J, Dexter D, Jenner P, Marsden C (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet 1:1269

    Article  CAS  PubMed  Google Scholar 

  • Schuh R, Clerc P, Hwang H-J, Mehrabiab Z, Bittman K, Chen H, Polster B (2011) Adaptation of microplate-based respirometry for hippocampal slices and analysis of respiratory capacity. J Neurosci Res 89:1979–1988

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH (2012a) Is alpha-synuclein in the colon a biomarker for premotor Parkinson’s disease? Evidence from 3 cases. Mov Disord 27(6):716–719

    Article  PubMed  Google Scholar 

  • Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, Kordower JH (2012b) Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease. Mov Disord 27(6):709–715

    Article  PubMed  Google Scholar 

  • Spillantini M, Schmidt M, Lee V, Trojanowski J, Jakes R, Goerdert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839–840

    Article  CAS  PubMed  Google Scholar 

  • Suh YH, Checler F (2002) Amyloid precursor protein, presenilins, and α-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s disease. Pharm Rev 54:469–525

    Article  CAS  PubMed  Google Scholar 

  • Vanden Berghe P, Tack J, Coulie B, Andrioli A, Bellon E, Janssens J (2000) Synaptic transmission induces transient Ca2+ concentration changes in cultured myenteric neurones. Neurogastroenterol Motil 12:117–124

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the UNSW Faculty of Medicine Research Grant to Dr Nady Braidy. Dr Nady Braidy is also the recipient of an Alzheimer’s Australia Viertel Foundation and NHMRC Early Career Postdoctoral Research Grant at the University of New South Wales. This work has also been supported by the Alzheimer’s Association (Grant#IIRG-08-89545) and by the Rebecca Cooper foundation (Australia).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Kam Yin Chan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Braidy, N., Gai, WP., Xu, Y.H. et al. Alpha-Synuclein Transmission and Mitochondrial Toxicity in Primary Human Foetal Enteric Neurons In Vitro. Neurotox Res 25, 170–182 (2014). https://doi.org/10.1007/s12640-013-9420-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12640-013-9420-5

Keywords

Navigation